6 insiders reported 12 Form 4 transactions for Drugs Made In America Acquisition Corp. (DMAA) over the past 18 months (most recent 2025-02-18). Recent activity: Drugs Made In America Acquisition LLC (Insider) Buy 30,000 shares, Stockwell Lynn (CEO and Exe. Chair of Board) Buy 30,000 shares, Drugs Made In America Acquisition LLC (Insider) Buy 400,000 shares, Drugs Made In America Acquisition LLC (Insider) Sell 400,000 shares, Drugs Made In America Acquisition LLC (Insider) Sell 5.7M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-18 | Drugs Made In America Acquisition LLC | Insider | Buy | 30,000 | $0 |
| 2025-02-18 | Stockwell Lynn | CEO and Exe. Chair of Board | Buy | 30,000 | $0 |
| 2025-02-04 | Drugs Made In America Acquisition LLC | Insider | Buy | 400,000 | $0 |
| 2025-02-04 | Drugs Made In America Acquisition LLC | Insider | Sell | 400,000 | $0 |
| 2025-02-04 | Drugs Made In America Acquisition LLC | Insider | Sell | 5.7M | $0 |
| 2025-02-04 | Stockwell Lynn | CEO and Executive COB | Buy | 400,000 | $0 |
| 2025-02-04 | Stockwell Lynn | CEO and Executive COB | Sell | 400,000 | $0 |
| 2025-02-04 | Stockwell Lynn | CEO and Executive COB | Sell | 5.7M | $0 |
| 2025-02-03 | Prasad Sridhar G. | Director | Buy | 100,000 | $0 |
| 2025-02-03 | Shulgan Myron W. | Director | Buy | 100,000 | $0 |
| 2025-02-03 | Do Catherine | Director | Buy | 100,000 | $0 |
| 2025-02-03 | Worman Glenn C. | CFO | Buy | 100,000 | $0 |
Source: SEC Form 4 filings · as of 2025-02-18